XML 34 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEET (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current Assets:    
Cash and Cash Equivalents $ 209,323 $ 706,350
Cash - Restricted (Note 6) 139,924 70,124
Accounts Receivable - net 293,197 805,809
Inventories (Note 3) 553,576 407,549
Prepaids Expenses 53,434 7,980
Total Current Assets 1,249,454 1,997,812
Property & Equipment - net (Note 4) 288,356 164,068
Other Assets:    
Intangible Assets - net (Note 5)) 2,841,810 3,026,564
Deferred Financing Costs - net (Note 6) 372,278 542,116
Deposits 2,353 2,543
Total Other Assets 3,216,441 3,571,223
Total Assets 4,754,251 5,733,103
Current Liabilities:    
Accounts Payable and Accrued Expenses 544,729 383,349
Accrued Interest on Convertible Notes (Note 6) 211,417 211,194
Accrued Officers Compensation (Note 9) 54,000 25,000
Common Stock to be Issued (Note 12) 100,832 150,871
Customer Deposits 23,968 14,105
Derivative Liability (Note 7) 4,419,365 7,665,502
Total Current Liabilities 5,354,311 8,450,021
Convertible Notes Payable, net of discount of $4,786,104 and $5,003,558 at June 30, 2014 and December 31, 2013, respectively (Note 6) 287,896 70,442
Total Long-term Liabilities 287,896 70,442
Total Liabilities 5,642,207 8,520,463
Commitments and Contingencies 0 0
Stockholders' Equity ( Deficiency):    
Cumulative Convertible Series A Preferred Stock; par value $0.01, 1,000,000 shares authorized; 510,000 shares issued and outstanding at June 30, 2014 and December 31, 2013 5,100 5,100
Cumulative Convertible Series B Preferred Stock; $1,000 stated value; 7.5% Cumulative dividend; 4,000 shares authorized; none issued and outstanding at June 30, 2014 and December 31, 2013 0 0
Common stock; par value $0.01, 200,000,000 shares authorized; 80,225,890 and 79,867,217 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively. 802,259 798,672
Additional Paid-in Capital 17,252,121 15,674,958
Accumulated Deficit (18,947,436) (19,266,090)
Total Stockholders' Deficiency (887,956) (2,787,360)
Total Liabilities and Stockholders' Deficiency $ 4,754,251 $ 5,733,103